These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3311733)

  • 1. In vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in twenty-nine European laboratories. European Study Group on Antibiotic Resistance.
    Eur J Clin Microbiol; 1987 Aug; 6(4):378-85. PubMed ID: 3311733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. The ESGAR Study Group (European Study Group on Antibiotic Resistance).
    Dornbusch K; Miller GH; Hare RS; Shaw KJ
    J Antimicrob Chemother; 1990 Jul; 26(1):131-44. PubMed ID: 2211434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of gram-negative bacilli and staphylococci from blood cultures to aminoglycoside antibiotics. Comparison of 3 in vitro investigations from Austria 1982-1988.
    Mittermayer H; Rotter M; Breitfellner G; Riezinger F; Thiel W; Binder L; Watschinger R
    Zentralbl Bakteriol; 1990 Apr; 272(4):448-57. PubMed ID: 2113808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro aminoglycoside resistance of gram-negative bacilli and staphylococci isolated from blood in Sweden 1980-1984.
    Bengtsson S; Bernander S; Brorson JE; Dornbusch K; Forsgren A; Hallander H; Henning C; Holm S; Malmborg AS; Nilsson L
    Scand J Infect Dis; 1986; 18(3):257-63. PubMed ID: 3738436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.
    Kabins SA; Nathan C; Cohen S
    Antimicrob Agents Chemother; 1976 Jul; 10(1):139-45. PubMed ID: 825021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR; Krafczyk TL
    Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside resistance among blood culture isolates.
    Huovinen P; Grönroos P; Herva E; Katila ML; Klossner ML; Renkonen OV; Toivanen P
    J Clin Microbiol; 1984 Jul; 20(1):65-9. PubMed ID: 6378968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
    Xiao Y; Hu Y
    Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycoside resistance patterns in Turkey.
    Akalin HE; Torun M; Alacam R
    Scand J Infect Dis; 1988; 20(2):199-203. PubMed ID: 2840733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of antibiotic resistance in blood and urine isolates from hospitalized patients. Report from a European collaborative study. European Study Group on Antibiotic Resistance (ESGAR).
    Dornbusch K; King A; Legakis N
    Scand J Infect Dis; 1998; 30(3):281-8. PubMed ID: 9790138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of aminoglycoside resistance. European data.
    Van Landuyt HW; Boelaert J; Glibert B; Gordts B; Verbruggen AM
    Am J Med; 1986 Jun; 80(6B):76-81. PubMed ID: 3089007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of gentamicin resistance in gram-negative bacteria in Czechoslovakia and correlation with its usage.
    Kettner M; Krćméry V
    Drugs Exp Clin Res; 1988; 14(8):511-7. PubMed ID: 2854783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of a disk diffusion method using semiconfluent growth in the determination of aminoglycoside resistance.
    Huovinen P; Herva E; Katila ML; Klossner ML; Renkonen OV; Toivanen P
    Acta Pathol Microbiol Immunol Scand B; 1986 Jun; 94(3):153-7. PubMed ID: 3739715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.
    Thornsberry C; Barry AL; Jones RN; Baker CN; Badal RE; Packer RR
    Antimicrob Agents Chemother; 1980 Aug; 18(2):338-45. PubMed ID: 7447410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of netilmicin susceptibility discs using bacteria with known aminoglycoside resistance patterns: correlation of in vitro and in vivo test results.
    Waitz JA; Hare RS; Moss EL; Sabatelli FJ; Schaffer TW; Waitz JA
    Scand J Infect Dis Suppl; 1980; Suppl 23():62-72. PubMed ID: 6937970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the resistance mechanisms of gentamicin-resistant Gram-negative bacilli and their susceptibility to tobramycin, netilmicin and amikacin.
    Maes P
    J Antimicrob Chemother; 1985 Mar; 15(3):283-9. PubMed ID: 3997704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
    Saavedra S; Vera D; Ramírez-Ronda CH
    Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin.
    Dhawan V; Marso E; Martin WJ; Young LS
    Antimicrob Agents Chemother; 1977 Jan; 11(1):64-73. PubMed ID: 836015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.